9 completed, 2 terminated. 5 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Terminated 1 |
Follow Childhood Acute Erythroleukemia (M6): new trials by email Literature Review of Childhood Acute Erythroleukemia (M6) trials Research Report on Childhood Acute Erythroleukemia (M6)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia mitoxantrone hydrochloride, cytarabine, peripheral blood stem cell transplantation - Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a) | Phase 1 | Terminated | University of Southern California | 10 | 2013-03-06 | 2018-03-30 |
| Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies cyclophosphamide, cyclosporine, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Completed | Fred Hutchinson Cancer Center | 43 | 2011-09-01 | 2017-05-19 |
| Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia laboratory biomarker analysis - Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia | Completed | Children's Oncology Group | 250 | 2010-03-01 | 2016-05-19 | |
| Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia laboratory biomarker analysis - Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7) | Completed | Children's Oncology Group | 20 | 2009-05-01 | 2016-05-17 | |
| Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia idarubicin, cytarabine, bortezomib - Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) | Phase 2 | Completed | National Cancer Institute (NCI) | 52 | 2008-04-01 | 2018-05-22 |
| Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies double-unit umbilical cord blood transplantation, cytogenetic analysis, bone marrow aspiration - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Completed | Case Comprehensive Cancer Center | 14 | 2007-09-01 | 2019-01-23 |
| Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes asparaginase, daunorubicin hydrochloride, cytarabine - Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia | Phase 3 | Completed | Children's Oncology Group | 205 | 2007-03-01 | 2022-01-28 |
| Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia idarubicin, cytarabine, bevacizumab - Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 2 | Terminated | National Cancer Institute (NCI) | 120 | 2004-10-01 | 2013-01-24 |
| Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia cytarabine, daunorubicin hydrochloride, etoposide - Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 3 | Completed | National Cancer Institute (NCI) | 720 | 2000-11-01 | 2013-06-04 |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome asparaginase, daunorubicin hydrochloride, fludarabine phosphate - Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7) | Phase 3 | Completed | National Cancer Institute (NCI) | 880 | 1996-08-01 | 2013-01-16 |
| High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma busulfan, cyclophosphamide, allogeneic bone marrow transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Completed | Case Comprehensive Cancer Center | 13 | 1988-03-01 | 2010-08-09 |
Leukemia, Myeloid, Acute (7) · Congenital Abnormalities (6) · Leukemia, Erythroblastic, Acute (6) · Leukemia, Megakaryoblastic, Acute (6) · Leukemia, Monocytic, Acute (6) · Leukemia, Eosinophilic, Acute (5) · Leukemia, Myelomonocytic, Acute (5) · Leukemia, Myelomonocytic, Chronic (4) · Burkitt Lymphoma (3) · Leukemia, Lymphocytic, Chronic, B-Cell (3) · Leukemia, Myeloid, Chronic-Phase (3) · Lymphoma, B-Cell, Marginal Zone (3) · Lymphoma, Extranodal NK-T-Cell (3) · Lymphoma, Follicular (3) · Lymphoma, Large B-Cell, Diffuse (3)
Hematologic Diseases (11) · Hemic and Lymphatic Diseases (11) · Leukemia (11) · Leukemia, Myeloid (11) · Neoplasms (11) · Neoplasms by Histologic Type (11) · Bone Marrow Diseases (8) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Chronic Disease (5) · Disease Attributes (5) · Myeloproliferative Disorders (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Myelodysplastic-Myeloproliferative Diseases (4) · Blood Protein Disorders (3)
Cytarabine (6) · Busulfan (5) · Cyclophosphamide (4) · Etoposide (4) · Cyclosporine (3) · Daunorubicin (3) · Idarubicin (3) · Peripheral Blood Stem Cell Transplantation (3) · Asparaginase (2) · Cyclosporins (2) · Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2) · Interleukin-2 (2) · Methotrexate (2) · Methylprednisolone (2)
National Cancer Institute (NCI) (4) · Children's Oncology Group (3) · Case Comprehensive Cancer Center (2) · Fred Hutchinson Cancer Center (1) · University of Southern California (1)
United States (11) · Australia (2) · Canada (2) · Puerto Rico (1)
Ann Mohrbacher (1) · Beverly Lange (1) · Brenda Cooper, MD (1) · Hillard Lazarus (1) · Jeffrey Moscow (1) · Jeffrey Taub, MD (1) · Jonathan Kolitz (1) · Marco Mielcarek (1) · Monica Thakar, MD (1) · Soheil Meshinchi, MD (1) · Srdan Verstovsek (1)
PMID 19304957, PMID 20056794, PMID 20413658, PMID 20522709, PMID 26764356, PMID 28389462, PMID 31375516, PMID 36184192, PMID 36815378, PMID 38295280, PMID 42085603
U10CA098543 (4), N01CM62202 (1), N01CM62204 (1), P30CA015704 (1), U10CA031946 (1)